Novel selective inhibitors applicable in viral replication, cancer and inflammation
Date: 12.6.2014
Technology offer: Novel selective inhibitors applicable in viral replication, cancer and inflammation
Summary: An Italian highly innovative company with business unit in the USA, has developed a robust pipeline of novel, proprietary, selective inhibitors for a number of distinct disease indications.
The company is seeking to leverage its internal programs through licensing collaborations or technological agreements.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
